Management of adult growth hormone deficiency.
The management of adults who have severe growth hormone deficiency (GHD) includes its recognition in susceptible patients, including all subjects who have any form of hypothalamic pituitary disorder. This article also focuses on the overall management of adults who have hypopituitarism and severe GHD. This includes aspects of diagnosis and management of growth hormone replacement therapy and the current status of its long-term safety. Some special circumstances, including the pregnant woman who has hypopituitarism, are discussed.
Johannsson
Gudmundur
G
Department of Endocrinology, Sahlgrenska University Hospital and the Sahlgrenska Academy, Gothenburg University, SE-413 45 Gothenburg, Sweden. gudmundur.johannsson@medic.gu.se
D000328:Adult; D000075202:Contraindications; D004393:Dwarfism, Pituitary / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D005260:Female; D020249:Hormone Replacement Therapy; D019382:Human Growth Hormone / Q000627:therapeutic use*; D006801:Humans; D008991:Monitoring, Physiologic; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy; D011994:Recombinant Proteins / Q000627:therapeutic use
D011994:Recombinant Proteins; D019382:Human Growth Hormone